Ultragenyx Pharmaceutical Inc.

Contributing Author

Recent Articles by Ultragenyx Pharmaceutical Inc.

May-20	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) RARE GlobeNewswire
May-14	Ultragenyx Underscores Continued Commitment to Rare Disease Innovation with 2024 Impact Report RARE GlobeNewswire
May-07	Ultragenyx to Participate at Bank of America's 2025 Healthcare Conference RARE GlobeNewswire
May-06	Ultragenyx Reports First Quarter 2025 Financial Results and Corporate Update RARE GlobeNewswire